Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999American Medical Association
Atlanta—For some time, anxiety and "watchful waiting" have been the usual prescription for women with an elevated risk of developing breast cancer. Now, however, a working group convened by the nation's largest group of cancer specialists cautiously suggests that physicians consider offering a risk-reduction measure—the drug tamoxifen—to healthy women age 35 and older who have an increased risk of developing the disease.
But this advice, presented in a new report unveiled at the annual meeting of the American Society of Clinical Oncology (ASCO), fell far short of a ringing endorsement of prescribing tamoxifen for healthy women.
Stephenson J. Experts Debate Drugs for Healthy Women With Breast Cancer Risk. JAMA. 1999;282(2):117-118. doi:10.1001/jama.282.2.117